Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1
Progressive supranuclear palsy (PSP) is a neurodegenerative disease characterized by aggregation of Tau, encoded by MAPT. Here, the authors perform an EWAS for PSP in prefrontal lobe tissue and find hypermethylation of DLX1 and its antisense transcript DLX1AS to associate with MAPT expression.
Main Authors: | Axel Weber, Sigrid C. Schwarz, Jörg Tost, Dietrich Trümbach, Pia Winter, Florence Busato, Pawel Tacik, Anita C. Windhorst, Maud Fagny, Thomas Arzberger, Catriona McLean, John C. van Swieten, Johannes Schwarz, Daniela Vogt Weisenhorn, Wolfgang Wurst, Till Adhikary, Dennis W. Dickson, Günter U. Höglinger, Ulrich Müller |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-07-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-018-05325-y |
Similar Items
-
iPS Cell-Based Model for MAPT Haplotype as a Risk Factor for Human Tauopathies Identifies No Major Differences in TAU Expression
by: Tabea Strauß, et al.
Published: (2021-08-01) -
Multireceptor fingerprints in progressive supranuclear palsy
by: Wang Zheng Chiu, et al.
Published: (2017-04-01) -
Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database
by: Emma Viscidi, et al.
Published: (2021-06-01) -
Testing the functional equivalence of the mammalian Dlx5 and Dlx6 proteins
by: Quach, Anna
Published: (2012) -
Clinical Features Observed in General Practice Associated With the Subsequent Diagnosis of Progressive Supranuclear Palsy
by: Mary J. Kwasny, et al.
Published: (2021-04-01)